Top compounds associated with response to RFPL3S


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.079 0.03
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.11 0.04
mRNA pac-1 CTRPv2 pan-cancer AAC 0.074 0.04
mRNA PF-184 CTRPv2 pan-cancer AAC 0.068 0.04
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.067 0.04
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.11 0.04
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.061 0.04
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.04
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.04
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
Download CSV